Alzamend Neuro, Inc.
For the period ended Apr 30, 2026. Filed Jul 22, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jul 22, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-K
Period ended 2025-04-30; filed 2025-07-22.
0001214659-25-010763
Item 1A. RISK FACTOR SUMMARYCurrent report: 10-K
Period ended 2026-04-30; filed 2026-07-22.
0001214659-26-008832
Item 1A. RISK FACTOR SUMMARYThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 1 previous paragraphs and 1 current paragraphs.
1 unchanged; 0 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 14 previous and 13 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
No paragraph wording changes were found after ignoring dates, whitespace, punctuation and numbering. Tables are outside this comparison.